2008 Summary
The Mid-Atlantic Venture Association, the Virginia Biotechnology Association, and the Tech Council of Maryland/MdBio co-hosted 2008 Mid-Atlantic Bio, their signature annual bioscience industry conference, October 22-24, 2008. Over the last four years, Mid-Atlantic Bio has gained recognition as a substantive, regionally-hosted forum that attracts national and international industry leaders.
Conference attendees heard from biotech industry leaders about innovations and advances in life sciences. Investors had an opportunity to learn in depth about the initiatives of individual bioscience companies and research organizations, while exhibitors showcased their capabilities and offerings to industry stakeholders.
2008 Mid Atlantic Bio attracted more than 850 attendees from 30 states and 10 countries, including life science organizations, venture and investment firms, academic and research institutions, and government agencies. With preeminent speakers from the life sciences community, record attendance, a sold-out conference hotel, and top-tier programming, Mid-Atlantic Bio has experienced continuous growth since its inception in 2005.
News
The 2009 Mid-Atlantic Bio Conference drew more than 750 participants—including a record number of more than 300 bioscience companies in attendance—for its annual bioscience and investor conference. For its fifth year, the conference brought together industry luminaries, innovators, capital sources, academic and research organizations, and government agencies representing 30 states and the international community.
Online registration deadline is Wednesday, November 4th at 12 p.m. EST. Onsite registration will be open thereafter at a higher rate. Register now to save hundreds!
On November 4-6, the Mid-Atlantic Bio Conference will be held at the Washington D.C. Convention Center. The event brings together people from all over the Mid-Atlantic region and beyond including national and international industry leaders, government representatives, executives, researchers, investors, entrepreneurs, and professional services firms—representing 30 states and 10 countries—in a unique forum to promote networking, business expansion, and technical-knowledge sharing.
Former presidential candidate Howard Dean will be one of the headliners at Mid-Atlantic Bio, the region’s annual biotech conference, next week. The annual biotech gathering organized by the Virginia Biotechnology Organization, the MdBio division of the Tech Council of Maryland and Mid-Atlantic Venture Association, will close its program Nov. 6 with Dean’s remarks on how health care reform will affect the bioscience industry.
